IRONWOOD PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$9.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$4.61M.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$4.89M, a 150.57% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$318.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $10.69M, a 15397.10% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $6.20M.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$20.21M, a 263.23% decline from fiscal 2023.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $12.38M.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$8.12M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$9.50M 10-Q · filed 2026-08-06 | -$9.82M derived: sum of 3 quarters · filed 2026-08-06 | $875.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$4.89M 10-Q · filed 2026-05-07 | -$5.20M derived: sum of 2 quarters · filed 2026-05-07 | $5.49M derived: sum of 3 quarters · filed 2026-05-07 | -$8.35M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$318.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.38M derived: sum of 2 quarters · filed 2026-02-26 | -$3.46M derived: sum of 3 quarters · filed 2026-08-06 | $6.20M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $10.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$3.14M derived: sum of 2 quarters · filed 2026-08-06 | $6.52M 10-Q · filed 2025-11-10 | $767.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$13.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.17M 10-Q · filed 2026-08-06 | -$9.93M derived: sum of 3 quarters · filed 2026-08-06 | -$9.86M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $9.66M 10-Q · filed 2026-05-07 | $3.91M derived: sum of 2 quarters · filed 2026-05-07 | $3.98M derived: sum of 3 quarters · filed 2026-05-07 | $1.98M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$5.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.68M derived: sum of 2 quarters · filed 2026-02-26 | -$7.68M derived: sum of 3 quarters · filed 2026-02-26 | -$20.21M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.93M derived: sum of 2 quarters · filed 2025-11-10 | -$14.46M 10-Q · filed 2025-11-10 | -$27.00M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$14.53M 10-Q · filed 2025-08-11 | -$27.07M derived: sum of 3 quarters · filed 2025-08-11 | -$20.48M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | -$12.53M 10-Q · filed 2025-05-12 | -$25.07M derived: sum of 2 quarters · filed 2025-05-12 | -$18.48M derived: sum of 3 quarters · filed 2025-05-12 | -$851.00K derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$12.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$5.95M derived: sum of 2 quarters · filed 2025-03-31 | $11.68M derived: sum of 3 quarters · filed 2025-03-31 | $12.38M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $6.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $24.22M derived: sum of 2 quarters · filed 2024-11-07 | $24.93M 10-Q · filed 2024-11-07 | $22.92M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-06-30 | $17.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $18.33M 10-Q · filed 2024-08-08 | $16.32M derived: sum of 3 quarters · filed 2025-03-31 | $20.98M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-03-31 | $705.00K 10-Q · filed 2024-05-09 | -$1.30M derived: sum of 2 quarters · filed 2025-03-31 | $3.35M derived: sum of 3 quarters · filed 2025-03-31 | -$294.00K derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2022-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.65M derived: sum of 2 quarters · filed 2025-03-31 | -$999.00K derived: sum of 3 quarters · filed 2025-03-31 | -$8.12M 10-K · filed 2025-03-31 | ||||
| 2022-09-30 | $4.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.01M derived: sum of 2 quarters · filed 2023-11-09 | -$6.11M 10-Q · filed 2023-11-09 | -$2.04M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-06-30 | -$3.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$10.77M 10-Q · filed 2023-08-09 | -$6.70M derived: sum of 3 quarters · filed 2024-02-16 | -$2.98M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-03-31 | -$7.12M 10-Q · filed 2023-05-04 | -$3.05M derived: sum of 2 quarters · filed 2024-02-16 | $667.00K derived: sum of 3 quarters · filed 2024-02-16 | -$1.82M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2021-12-31 | $4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $7.78M derived: sum of 2 quarters · filed 2024-02-16 | $5.30M derived: sum of 3 quarters · filed 2024-02-16 | -$2.64M 10-K · filed 2024-02-16 | ||||
| 2021-09-30 | $3.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.23M derived: sum of 2 quarters · filed 2022-11-03 | -$6.71M 10-Q · filed 2022-11-03 | -$5.82M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-06-30 | -$2.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$10.43M 10-Q · filed 2022-08-04 | -$9.54M derived: sum of 3 quarters · filed 2023-02-16 | -$4.09M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-03-31 | -$7.94M 10-Q · filed 2022-05-05 | -$7.05M derived: sum of 2 quarters · filed 2023-02-16 | -$1.60M derived: sum of 3 quarters · filed 2023-02-16 | -$3.70M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2020-12-31 | $890.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $6.34M derived: sum of 2 quarters · filed 2023-02-16 | $4.25M derived: sum of 3 quarters · filed 2023-02-16 | -$7.52M 10-K · filed 2023-02-16 | ||||
| 2020-09-30 | $5.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.35M derived: sum of 2 quarters · filed 2021-11-04 | -$8.41M 10-Q · filed 2021-11-04 | -$3.84M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-06-30 | -$2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$13.86M 10-Q · filed 2021-08-05 | -$9.29M derived: sum of 3 quarters · filed 2022-02-18 | -$21.36M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-03-31 | -$11.77M 10-Q · filed 2021-05-06 | -$7.19M derived: sum of 2 quarters · filed 2022-02-18 | -$19.26M derived: sum of 3 quarters · filed 2022-02-18 | -$22.64M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2019-12-31 | $4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | -$7.50M derived: sum of 2 quarters · filed 2022-02-18 | -$10.88M derived: sum of 3 quarters · filed 2022-02-18 | -$32.70M 10-K · filed 2022-02-18 | ||||
| 2019-09-30 | -$12.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$15.45M derived: sum of 2 quarters · filed 2020-11-05 | -$37.27M 10-Q · filed 2020-11-05 | -$27.61M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-30 | -$3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$25.20M 10-Q · filed 2020-08-06 | -$15.54M derived: sum of 3 quarters · filed 2021-02-17 | -$24.62M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | -$21.82M 10-Q · filed 2020-05-06 | -$13.45M 10-Q · filed 2019-05-02 | -$12.16M derived: sum of 2 quarters · filed 2021-02-17 | -$21.24M derived: sum of 3 quarters · filed 2021-02-17 | -$6.85M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2018-12-31 | $9.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $582.00K derived: sum of 2 quarters · filed 2021-02-17 | $14.98M derived: sum of 3 quarters · filed 2021-02-17 | $2.68M 10-K · filed 2021-02-17 | $8.06M 10-K · filed 2019-02-25 | |||
| 2018-09-30 | -$9.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $5.31M derived: sum of 2 quarters · filed 2019-10-31 | -$6.99M 10-Q · filed 2019-10-31 | -$2.77M 10-Q · filed 2018-11-06 | -$8.05M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-06-30 | $14.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $2.10M 10-Q · filed 2019-07-30 | $6.28M 10-Q · filed 2018-08-06 | $1.03M derived: sum of 3 quarters · filed 2020-02-13 | -$284.00K derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-03-31 | -$12.30M 10-Q · filed 2019-05-02 | -$13.37M derived: sum of 2 quarters · filed 2020-02-13 | -$14.68M derived: sum of 3 quarters · filed 2020-02-13 | -$14.79M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$2.38M derived: sum of 2 quarters · filed 2020-02-13 | -$2.49M derived: sum of 3 quarters · filed 2020-02-13 | -$7.72M 10-K · filed 2020-02-13 | -$6.84M 10-K · filed 2018-02-22 | |||
| 2017-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$1.42M derived: sum of 2 quarters · filed 2018-11-06 | -$6.66M 10-Q · filed 2018-11-06 | -$3.28M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | -$107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$5.34M 10-Q · filed 2018-08-06 | -$1.96M derived: sum of 3 quarters · filed 2019-02-25 | $16.65M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | -$5.24M 10-Q · filed 2018-05-04 | -$1.86M derived: sum of 2 quarters · filed 2019-02-25 | $16.76M derived: sum of 3 quarters · filed 2019-02-25 | $22.55M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $22.00M derived: sum of 2 quarters · filed 2019-02-25 | $27.79M derived: sum of 3 quarters · filed 2019-02-25 | $19.68M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | $18.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $24.41M derived: sum of 2 quarters · filed 2017-11-02 | $16.30M 10-Q · filed 2017-11-02 | $17.70M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $5.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$2.31M 10-Q · filed 2017-08-03 | -$919.00K derived: sum of 3 quarters · filed 2018-02-22 | $2.11M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | -$8.10M 10-Q · filed 2017-05-08 | -$6.71M derived: sum of 2 quarters · filed 2018-02-22 | -$3.68M derived: sum of 3 quarters · filed 2018-02-22 | -$2.67M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $4.43M derived: sum of 2 quarters · filed 2018-02-22 | $5.44M derived: sum of 3 quarters · filed 2018-02-22 | -$1.55M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $4.04M derived: sum of 2 quarters · filed 2016-11-07 | -$2.95M 10-Q · filed 2016-11-07 | -$4.34M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$5.98M 10-Q · filed 2016-08-08 | -$7.37M derived: sum of 3 quarters · filed 2017-02-22 | $3.14M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | -$6.99M 10-Q · filed 2016-05-10 | -$8.38M derived: sum of 2 quarters · filed 2017-02-22 | $2.13M derived: sum of 3 quarters · filed 2017-02-22 | $2.48M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $9.12M derived: sum of 2 quarters · filed 2017-02-22 | $9.47M derived: sum of 3 quarters · filed 2017-02-22 | $1.43M 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | $10.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $10.86M derived: sum of 2 quarters · filed 2015-11-05 | $2.82M 10-Q · filed 2015-11-05 | $4.96M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $351.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$7.69M 10-Q · filed 2015-08-07 | -$5.55M derived: sum of 3 quarters · filed 2016-02-19 | -$9.32M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | -$8.04M 10-Q · filed 2015-05-06 | -$5.90M derived: sum of 2 quarters · filed 2016-02-19 | -$9.67M derived: sum of 3 quarters · filed 2016-02-19 | -$28.66M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$1.63M derived: sum of 2 quarters · filed 2016-02-19 | -$20.62M derived: sum of 3 quarters · filed 2016-02-19 | -$11.72M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | -$3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$22.76M derived: sum of 2 quarters · filed 2014-11-05 | -$13.87M 10-Q · filed 2014-11-05 | $7.06M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2013-06-30 | -$19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$10.10M 10-Q · filed 2014-08-05 | $10.83M derived: sum of 3 quarters · filed 2015-02-18 | $7.43M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2013-03-31 | $8.90M 10-Q · filed 2014-04-29 | $29.83M derived: sum of 2 quarters · filed 2015-02-18 | $26.43M derived: sum of 3 quarters · filed 2015-02-18 | $35.37M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2012-12-31 | $20.93M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $17.53M derived: sum of 2 quarters · filed 2015-02-18 | $26.47M derived: sum of 3 quarters · filed 2015-02-18 | $24.24M 10-K · filed 2015-02-18 | ||||
| 2012-09-30 | -$3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $5.54M derived: sum of 2 quarters · filed 2013-10-28 | $3.31M 10-Q · filed 2013-10-28 | $9.46M derived: sum of 4 quarters · filed 2014-02-07 | ||||
| 2012-06-30 | $8.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $6.71M 10-Q · filed 2013-08-08 | $12.86M derived: sum of 3 quarters · filed 2014-02-07 | $10.23M derived: sum of 4 quarters · filed 2014-02-07 | ||||
| 2012-03-31 | -$2.23M 10-Q · filed 2013-04-23 | $3.92M derived: sum of 2 quarters · filed 2014-02-07 | $1.29M derived: sum of 3 quarters · filed 2014-02-07 | $5.82M derived: sum of 4 quarters · filed 2014-02-07 | ||||
| 2011-12-31 | $6.15M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | $3.52M derived: sum of 2 quarters · filed 2014-02-07 | $8.05M derived: sum of 3 quarters · filed 2014-02-07 | $5.09M 10-K · filed 2014-02-07 | ||||
| 2011-09-30 | -$2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $1.90M derived: sum of 2 quarters · filed 2012-11-06 | -$1.06M 10-Q · filed 2012-11-06 | -$1.33M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $4.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $1.57M 10-Q · filed 2012-08-07 | $1.30M derived: sum of 3 quarters · filed 2013-02-21 | $3.89M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | -$2.96M 10-Q · filed 2012-05-10 | -$3.23M derived: sum of 2 quarters · filed 2013-02-21 | -$647.00K derived: sum of 3 quarters · filed 2013-02-21 | |||||
| 2010-12-31 | -$271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $2.31M derived: sum of 2 quarters · filed 2013-02-21 | $2.74M 10-K · filed 2013-02-21 | |||||
| 2010-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $3.01M 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | $425.00K 10-Q · filed 2011-08-12 | |||||||
| 2009-12-31 | $1.73M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |